ArticleEuropean radiology2026
Early prediction of periventricular leukomalacia from MRI changes: a machine learning approach for risk stratification.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incremental predictive value of a CT-based deep learning radiomics model for differentiating benign and malignant pleural effusions.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesTo develop an accessible model integrating clinical, MRI, and radiomic features to predict periventricular leukomalacia (PVL) in high-risk infants. MATERIALS AND
methodsTwo hundred and seventeen infants (2015-2022) with suspected motor abnormalities, stratified into training (n = 124), internal validation (n = 31), and external validation (n = 62) cohorts by MRI scanners. Radiomic features were extracted from white matter regions on axial sequences. Feature selection employed T-tests, correlation filtering, Random Forest, and LASSO regression. Multivariate logistic models were evaluated by receiver operating characteristic (ROC), accuracy, sensitivity, specificity, positive predictive value, negative predictive value, calibration, decision curve analysis (DCA), net reclassification index (NRI), and integrated discrimination improvement (IDI).
resultsClinical predictors (gestational age, neonatal hypoglycemia, hypoxic-ischemic events, infection) and MRI features (dilated lateral ventricle, delayed myelination, and periventricular abnormal signal) were retained through univariate and multivariate screening. Five clinical predictive models, including clinical model (Model C), MRI model (Model M), Clinical + MRI model (Model C + M), radiomic model and Clinical + MRI + Radiomics model (Model C + M + R), were developed and validated using internal testing, bootstrapping, and external cohorts. Among them, Model C + M + R achieved the best overall performance, with an area under curve (AUC) of 0.96 (95% CI: 0.90-1.00), accuracy of 0.87 (95% CI: 0.76-0.94), sensitivity of 0.88, specificity of 0.85, PPV of 0.96, and NPV of 0.65 in the external validation cohort. Comparison with Model C + M, Model C + M + R demonstrated significant reclassification (NRI = 0.631, p < 0.001) and discrimination improvements (IDI = 0.037, p = 0.020).
conclusionConventional MRI-derived radiomics enhances PVL risk stratification. Interpretable accessible model for clinical use provides a new tool for high-risk infant evaluation. KEY POINTS: Question Periventricular leukomalacia requires early identification to optimize neurorehabilitation. Early white matter injury in infants is challenging to identify through conventional MRI visual assessment. Findings The clinical-MRI-radiomic model demonstrates the best performance for predicting PVL, with an AUC of 0.93 in the training and 0.96 in the external validation cohort. Clinical relevance An accessible and interpretable predictive tool for periventricular leukomalacia prediction has been developed and validated, which may enable earlier targeted interventions.
Indexed as
Identifiers
40986046What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.